ZNRF3
Basic information
Region (hg38): 22:28883572-29057488
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- ZNRF3-related disorder (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNRF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 51 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 8 | 0 | 53 | 5 | 2 |
Variants in ZNRF3
This is a list of pathogenic ClinVar variants found in the ZNRF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-28883835-C-G | Likely benign (Jun 01, 2024) | |||
22-28883913-G-T | Likely benign (Nov 01, 2023) | |||
22-28883932-A-G | not specified | Uncertain significance (Oct 22, 2021) | ||
22-28883954-TG-T | ZNRF3-related disorder | Uncertain significance (May 29, 2024) | ||
22-28987086-T-C | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29043333-C-T | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29043380-G-T | not specified | Uncertain significance (Aug 19, 2024) | ||
22-29044780-C-A | not specified | Uncertain significance (Jan 26, 2023) | ||
22-29044825-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
22-29044880-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
22-29046756-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
22-29046795-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
22-29046801-G-A | not specified | Uncertain significance (Aug 11, 2022) | ||
22-29046827-A-C | not specified | Uncertain significance (Oct 04, 2024) | ||
22-29046849-G-A | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29046858-G-A | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29048396-G-A | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29048432-G-A | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29048434-G-A | Uncertain significance (Apr 08, 2024) | |||
22-29048435-T-C | ZNRF3-associated neurodevelopmental disorder | Uncertain significance (Dec 19, 2024) | ||
22-29048440-C-T | not specified | Uncertain significance (Dec 21, 2021) | ||
22-29048441-C-G | ZNRF3-related disorder | Pathogenic (May 29, 2024) | ||
22-29048441-C-T | not specified | Uncertain significance (Sep 20, 2024) | ||
22-29048457-C-A | Likely benign (Aug 01, 2024) | |||
22-29048470-C-G | not specified | Uncertain significance (Dec 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNRF3 | protein_coding | protein_coding | ENST00000544604 | 9 | 173896 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0112 | 124748 | 0 | 47 | 124795 | 0.000188 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.975 | 482 | 546 | 0.883 | 0.0000357 | 5977 |
Missense in Polyphen | 123 | 192.39 | 0.63933 | 2060 | ||
Synonymous | -1.97 | 280 | 241 | 1.16 | 0.0000170 | 1990 |
Loss of Function | 4.51 | 4 | 31.2 | 0.128 | 0.00000163 | 357 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000289 | 0.000159 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00159 | 0.000883 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination and subsequent degradation of Wnt receptor complex components Frizzled and LRP6. Acts on both canonical and non- canonical Wnt signaling pathway. Acts as a tumor suppressor in the intestinal stem cell zone by inhibiting the Wnt signaling pathway, thereby resticting the size of the intestinal stem cell zone. {ECO:0000269|PubMed:22575959}.;
- Pathway
- Signaling by WNT;Signal Transduction;Regulation of FZD by ubiquitination;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.134
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.49
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.509
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.764
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Znrf3
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein ubiquitination;Wnt receptor catabolic process;limb development;stem cell proliferation;negative regulation of canonical Wnt signaling pathway;negative regulation of non-canonical Wnt signaling pathway;regulation of Wnt signaling pathway, planar cell polarity pathway
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- ubiquitin-protein transferase activity;frizzled binding;protein binding;metal ion binding;ubiquitin protein ligase activity